NICE set to recommend alitretinoin
This article was originally published in Scrip
Executive Summary
NICE, the health technology assessment agency for the national health service in England and Wales, has made changes to its draft guidance on using Basilea Pharmaceutica's Toctino (alitretinoin) in the treatment of adults with severe chronic hand eczema but it is still preparing to recommend the product as cost-effective.